Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

November 16, 2015November 16, 2015

Study Presented at ABCT Annual Convention Shows Anxiety Sensitivity is Associated with Poor Asthma Outcomes

Asthma, News

Anxiety sensitivity (AS) refers to the fear of behaviors or sensations associated with the experience of anxiety. Bodily sensations related to anxiety are misattributed as a harmful experience, causing more intense anxiety ... Read more

November 13, 2015November 13, 2015

Potential New Cystic Fibrosis Therapy, CTP-656, Begins Phase 1 Study

Cystic Fibrosis, News

Concert Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on utilizing its DCE Platform® (deuterated chemical entity platform) to create novel small molecule drugs, recently announced that it has initiated a Phase ... Read more

November 13, 2015November 16, 2015

Complexa’s CXA-10 To Be Tested as PAH Therapy in Upcoming Round of Phase 2 Trials

News, Pulmonary Hypertension

Complexa Inc., a biopharmaceutical company developing therapies for fibrosis and inflammation-associated orphan conditions, recently announced the conclusion of a broad Phase 1 clinical development program for its drug candidate CXA-10, as ... Read more

November 12, 2015November 12, 2015

Novel Severe Lung Disease Drug Therapy Pushing Forward

Idiopathic Pulmonary Fibrosis, News

aTyr Pharma, Inc., a biotherapeutics company engaged in the discovery and clinical development of innovative Physiocrine-based medicines for patients suffering from severe rare diseases, recently announced that it has designated ... Read more

November 11, 2015November 11, 2015

Asthma Education Helps Keep Hispanic Children Healthy

Asthma, News

In a recent study published online in the journal Pediatric Allergy, Immunology, and Pulmonology, a team of researchers led by Genny Carrillo, MD, ScD, MPH, MSPH, from the School of ... Read more

November 10, 2015November 10, 2015

Novel PAH Drug to Be Tested in Clinical Trial

News, Pulmonary Hypertension

Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company committed to bringing to market novel products for the treatment of orphan diseases, recently announced that it has completed a license agreement with Nippon ... Read more

November 9, 2015November 9, 2015

In CF, Manipulating a Gene Triggers Inflammatory Response

Cystic Fibrosis, News

Findings from a recent study published in the Journal of Inflammation showed that knockdown of the CFTR gene of two intestinal epithelial cell lines triggers an inflammatory response, which may ... Read more

November 5, 2015November 9, 2015

COPD Exacerbations Linked to Increased Levels of Lung Neuropeptide

COPD, News

Increased levels of serum vasoactive intestinal peptide were found to be associated with acute exacerbations in patients with chronic obstructive pulmonary disease (COPD), according to the findings of a recent ... Read more

November 4, 2015November 4, 2015

Chronic Obstructive Pulmonary Disease Found in Asymptomatic Smokers

News

Prevalence of chronic obstructive pulmonary disease (COPD) in asymptomatic smokers is 1.5% and these individuals would benefit from early interventions — both therapeutic and smoking cessation counseling, according to the ... Read more

November 3, 2015November 3, 2015

Aggressive Lung Cancer Linked to Mutations in EphA2 Enzyme

Lung Cancer, News

In a recent study published in the journal Proceedings of the National Academy of Sciences, a team of researchers from the Salk Institute have discovered that a mutated enzyme, called ... Read more